INIS
patients
100%
reviews
63%
skin
52%
women
31%
dermatitis
31%
therapy
31%
covid-19
31%
symptoms
28%
eczema
22%
assessments
19%
congenital diseases
17%
skin diseases
17%
side effects
12%
spectra
10%
pathogenesis
10%
diseases
10%
proteins
10%
gene therapy
10%
genetics
9%
comparative evaluations
9%
testing
7%
eruption
7%
evaluation
7%
hypertension
6%
pregnancy
6%
reduction
6%
hypothyroidism
6%
erythema
6%
vitamin a
6%
quality of life
6%
Keyphrases
Ichthyosis
63%
Molecular Treatment
31%
COVID-19
31%
COVID-19 Patients
31%
Dupilumab
31%
Childbearing Women
31%
Cutaneous Lesions
31%
Alitretinoin
31%
Atopic Dermatitis
31%
Filaggrin
31%
Treatment Modalities
31%
Skin Lesions
25%
Chilblains
19%
Severity Index
16%
Pathophysiology
14%
Autosomal Recessive Congenital Ichthyosis
10%
Investigator's Global Assessment
10%
Pathogenic Variants
9%
Acitretin
8%
Disease Spectrum
7%
Biological Therapeutics
7%
Cornification
7%
Gene Therapy
7%
Ongoing Trials
7%
New Advances
7%
Effective Treatment
7%
New Therapies
7%
Netherton Syndrome
7%
Inherited Skin Disease
7%
Constant Development
7%
Pharmacology, Toxicology and Pharmaceutical Science
Ichthyosis
63%
Dupilumab
31%
Alitretinoin
31%
Atopic Dermatitis
31%
Filaggrin
31%
Eczema
14%
Skin Disease
8%
Pathophysiology
6%
Replacement Therapy
6%
Disease
6%
Netherton Disease
6%
Etretin
6%